Text Size

Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (Stroke08)

This study has been completed.
Sponsor:
Information provided by:
Klinikum Ludwigshafen
ClinicalTrials.gov Identifier:
NCT00812656
First received: December 19, 2008
Last updated: December 2, 2009
Last verified: December 2009
History of Changes
  Purpose

The purpose of this study is to investigate changes in new plasma stroke biomarker panel in patients undergoing cardiac surgery with the use of cardiopulmonary bypass.


Condition
Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Resource links provided by NLM:

MedlinePlus related topics: Heart Surgery
U.S. FDA Resources

Further study details as provided by Klinikum Ludwigshafen:

Primary Outcome Measures:
  • Change in stroke index [ Time Frame: day before surgery; first and second day postoperatively ] [ Designated as safety issue: No ]

Enrollment: 50
Study Start Date: December 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Stroke Panel group
Patients undergoing cardiac surgery with the use of cardiopulmonary bypass

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Adult patients undergoing cardiac surgery with the use of cardiopulmonary bypass

Criteria

Inclusion Criteria:

  • Age > 18 years
  • Elective cardiac surgery with the use of cardiopulmonary bypass

Exclusion Criteria:

  • Patients undergoing emergent procedures
  • Patients with preoperative mechanical support
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00812656

Locations
Germany
Klinikum Ludwigshafen
Ludwigshafen, RLP, Germany, 67063
Sponsors and Collaborators
Klinikum Ludwigshafen
Investigators
Principal Investigator: Stefan W Suttner, MD Klinikum Ludwigshafen
  More Information

No publications provided

Responsible Party: Prof. Dr. J. Boldt, Klinikum Ludwigshafen
ClinicalTrials.gov Identifier: NCT00812656     History of Changes
Other Study ID Numbers: StrokePanel08
Study First Received: December 19, 2008
Last Updated: December 2, 2009
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

ClinicalTrials.gov processed this record on May 23, 2013